{"nctId":"NCT02525796","briefTitle":"Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism","startDateStruct":{"date":"2016-01","type":"ACTUAL"},"conditions":["Primary Hyperparathyroidism"],"count":69,"armGroups":[{"label":"Placebo + Cinacalcet","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo","Drug: Cinacalcet"]},{"label":"Amiloride + Cinacalcet","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: amiloride","Drug: Cinacalcet"]},{"label":"Eplerenone + Cinacalcet","type":"EXPERIMENTAL","interventionNames":["Drug: eplerenone","Drug: Cinacalcet"]}],"interventions":[{"name":"eplerenone","otherNames":[]},{"name":"amiloride","otherNames":[]},{"name":"Placebo","otherNames":[]},{"name":"Cinacalcet","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* physician diagnosis of active P-HPTH (Serum calcium \\> upper limit of reference range and serum PTH \\> ULRR; or Serum Calcium \\> ULRR AND serum PTH \\> 30 pg/mL; or Serum Calcium within 0.2 mg/dL of the ULRR and PTH\\>ULRR).\n* negative pregnancy test in women aged 18-45\n\nExclusion Criteria:\n\n* estimated glomerular filtration rate \\< 60mL/min/1,73m2\n* serum potassium \\> 5.0 mmol/L\n* age \\<18 or \\>80 years\n* diabetes that is not well controlled (HbA1c\\>8%)\\\\\n* liver failure\n* heart failure\n* history of myocardial infarction or stroke\n* active use of lithium\n* active chronic inflammatory conditions (such as inflammatory bowel disease, rheumatoid arthritis, sarcoidosis)\n* initiation within 3 months of bisphosphonates or cinacalcet\n* need for imminent parathyroidectomy (within the next 6-8 weeks) as determined by their endocrinologist or surgeon\n* absolute serum calcium \\>13.0 mg/dL\n* positive pregnancy test on any of the study visits for women ages 18-45.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Parathyroid Hormone Levels","description":"Change in circulating PTH levels before and after 4 weeks of double-blinded intervention when compared to placebo","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.0","spread":null},{"groupId":"OG001","value":"-3.7","spread":null},{"groupId":"OG002","value":"0.8","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Calcium Levels","description":"Change in serum calcium levels before and after intervention when compared to placebo","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1","spread":null},{"groupId":"OG001","value":"0.0","spread":null},{"groupId":"OG002","value":"0.1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":14},"commonTop":["hyperkalemia","low egfr","hypocalcemia","low blood pressure"]}}}